Search

everythinglearnresearchcommunity

for

Search:↓

Stem cells slowed lung tumor growth but increased colon tumor growth in mice.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

More precise, personalized therapies are needed for autoimmune diseases.

Skin pigmentation varies due to genetics, UV exposure, and drugs, with treatments available but requiring medical advice.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Skin pigmentation varies due to genetics, UV exposure, and medications, with treatments available but requiring medical advice.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Chitosan–hydroxyapatite biocomposites are promising for tissue engineering due to their safety and ability to support healing.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

IBD treatment is complex and requires personalized approaches due to varying patient responses.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Defective repair processes may cause immune activation and inflammation in psoriatic disease.

Targeting autophagy can help treat skin disorders like vitiligo and atopic dermatitis.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Improving human hair follicle models is crucial for better hair loss treatments.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.